Japanese Journal of Ophthalmology and Research
Online ISSN: 2732-4516
Dr. Kyung Chul Yoon
Chairman,Dept. of Ophthalmology, Chonnam National University Medical School and Hospital,South Korea

Japanese Journal of Ophthalmology and Research is devoted to publishing the highest quality innovative papers in the field of Ophthalmology


Ophthalmology is the branch of medicine that deals with the diagnosis, treatment and prevention of diseases of the eye and visual system.


The eye, its surrounding structures and the visual system can be affected by a number of clinical conditions. Ophthalmology involves diagnosis and therapy of such conditions, along with microsurgery.


Journal considers topics on Cornea and External Disease, Ocular oncology, Clinical Ophthalmology, Primary & Secondary Eye care, Glaucoma, Experimental Ophthalmology, Neuro-Ophthalmology, Albinism, Corneal Neovascularization, Macular Degeneration, Conjunctiva, Hypertensive Retinopathy, Ocular Migraine,  Ophthalmic imaging , Ophthalmoscopy , Lacrimal System, Retinal Diseases and Retinal Disorders, Cataract and Refractive Surgery, Diabetic Microvascular Complications, Pediatric Ophthalmology, Vision Problems , Ophthalmology Case Reports,   Diabetic Retinopathy, Myopia ,   Ophthalmology and Visual Science, Conjunctivitis, Brain and Optical Pathway, Congenital Syndromes, Malformations and Abnormalities,  Iris and Ciliary Body, Cornea and Corneal Diseases.


Authors are requested to submit their manuscript at Online Manuscript Submission or send as an e-mail attachment to the following email id: submissions@medicalpressopenaccess.uk


This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License.


Dr. Borja F. Corcóstegui

Dr. Borja F. Corcóstegui obtained his degree as a Medical Doctor in 1975 and in Ophthalmology Specialist in 1978 He specialized in Vitreo-Retina after visiting several centres in Europe and the United States of America.. Professor of Ophthalmology at Universidad Autónoma de Barcelona since 1991. He is also a joint founder of Instituto de Microcirugia Ocular (IMO) in  Barcelona, current Medical Director and current IMO Research Fundation Board member. He is also the Director of the Scientific Council of European School for Advanced Studies in Ophthalmology (ESASO).  in Lugano,  Switzerland and current Council’s President of ESASO Foundation since 2016. Member of Royal Acedemy of Medicine since 2016. Member of Royal European Doctors  Academy  since 2017.



Dr. Borja F. Corcóstegui

Professor of Ophthalmology, Universitat Autonoma De Barcelona, Spain

Editorial Board

  •    Dr. Kyung Chul Yoon, Professor, Dept. of Ophthalmology, Chonnam National University Medical School and Hospital, South Korea
  •    Dr. Michael Robert Kozlowski,Professor, Midwestern University / Arizona College of Optometry,USA
  •    Dr. Dimitrios P Besinis, Ophthalmic Eye Surgeon,Nea Smyrni, Athens, Greece
  •    Dr. B. Wieb van der Meer, Professor, Western Kentucky University, Bowling Green, Kentucky, USA
  •    Dr. Yasuo Iwasaki, Professor and Chairman, Toho University Omori Hospital, Japan
  •    Dr.Hamid Mahoozi, Regio Kliniken, Pinneberg, Germany
  •    Dr. Junpeng Qi, Research Associate, The Scripps Research Institute, Florida, USA
  •     Dr. Maha Abdeladhim, University of Uniformed Services for the Health Sciences, USA
  •    Dr. Haider Abdul-Lateef Mousa , College of Medicine, University of Basrah, Iraq

Instructions for Authors

Article Preparation Guidelines

Manuscript title: The article title should not exceed more than 30 words. (Times New Roman font, bold, font size-15)

Author Information: Mention complete names and affiliation of all authors and include complete details of corresponding author such as Telephone number, email id and Fax. (Times New Roman font, bold, font size-11)

Abstract: The abstract should be concise and briefly explain the purpose of the research, the principle results and the conclusion. It should not be more than 350. Authors should mention minimum of 3 key words. (Times New Roman font, bold, font size-11)


Introduction: It should clearly State the objectives of the work and also provide the adequate background information, avoiding a detailed literature survey or a summary of the results. (Times New Roman font, bold, font size-11)

Materials and Methods: This part should provide complete details that would facilitate all procedures to be reciprocated. (Times New Roman font, bold, font size-11)

Results: The results part should be clear and explain concisely. (Times New Roman font, bold, font size-11)

Conclusions: These sections should clearly explain the importance and relevance of the article. (Times New Roman font, bold, font size-11)

Acknowledgement: Mention the individuals, institutions, grant details or research centers who contributed help during the research period. (Times New Roman font, bold, font size-11) Conflicts of Interest: Kindly mention any potential conflicts of interest. (Times New Roman font, bold, font size-11)

Funding: Kindly mention if any funding or grants approve for the study. (Times New Roman font, bold, font size-11)

References: The style of referencing used is the Vancouver style. Author name followed by initials, Article title, journal title, Year of publication, volume number, issue number and page number. (Times New Roman font, bold, font size-11)

Tables: All the tables should be cited in the text and description should be given below the table.

Figures: Author are requested to provide high-resolution images,. The aim of the figure legend should be to describe the key messages of the figure and the figure should also be discussed in the text. If a figure has been published before, authors need to submit written permission letter from the copyright holder to reproduce the materials. Figure legend should begin with term 'Figure' followed by figure number (e.g. 'Figure 1').

Article Processing Fee: Medical press open access is a self-funded open access publisher and its operation solely depends on the fee received from the authors.

Authors are requested to make payment once the article has been accepted for publication.


         Manuscript Type

Article Processing Fee



       All types of Articles



Refund Policy : The publication fee becomes due once the article is accepted and concern article authors are solely responsible to pay the article processing fee and also refunds will not be entertain.

Note: The article processing fee may vary based on the extensive editing, number of images, complex equations etc.

Volume 2
Issue 1
Inhibition of Retinal Pigment Epithelial Cell Senescence by Metformin: Implications for the Treatment of Macular Degeneration

Michael R. Kozlowski Bryan Grossman Alex Kneeland Shelby Zemski Abretia Crandell Roni E. Kozlowski


Nov 25 2020

DOI : https://doi.org/10.31546/2732-4516.1005

Optical Coherence Tomography Retinal and Optical Disc Imaging in Covid-19 Patients

Alyne Z. Simao Julia C. Andrade Beatriz Harumi Yuda Nakagome Gabriel C. Andrade João Paulo Muaccad Gama Ronaldo Y. Sano Niro Kasahara Maria Auxiliadora M. Frazao


Nov 27 2020

DOI : https://doi.org/10.31546/2732-4516.1008

Volume 1
Issue 1

The Restored Eye Model

B.Wieb Van Der Meer

Short Communication

Jan 15 2019

DOI : https://doi.org/10.31546/JJOAR.1001

Corneal Suture Abscess Lead to Wound Dehiscence and Endophthalmitis after Vigorous Eye Rubbing: A Case Report

Majed Alkharashi Amjad Fayez Alshehri Omar M. Alabbasi Rawan Nasser Althaqib

Case Report

Jan 23 2019

DOI : https://doi.org/10.31546/JJOAR.1002

Acquired Bilateral Central Vision Loss in a Young Adult Due to “Poppers Maculopathy”

Geoffrey Law Geoffrey Ching Gavin Docherty Eduardo Navajas

Case Report

Aug 07 2019

DOI : https://doi.org/10.31546/JJOAR.1004



Updating Soon

Submit Manuscript

Japanese Journal of Ophthalmology and Research welcome Online Manuscript Submission or send as an e-mail attachment to the Editorial Office:  submissions@medicalpressopenaccess.uk



Medical Press Open Access

Registered Office Address:
71-75 Shelton Street, Covent Garden
United Kingdom
Email: info@medicalpressopenaccess.uk

Phone: +44-2038077821